Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines,…
Blog
Bausch Health Announces Pricing Of Private Offering Of Senior Secured Notes
Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health” or the “Company”) announced today that it has…
Digital Diagnostics Provides New Designation to Top Executives
Digital Diagnostics recently announced the designation of Co-Founder to the company’s CEO and President/COO, John Bertrand and Seth Rainford,…
Aeromics and Simcere Announce the First-In-Human Dosing of Chinese Healthy Volunteers in Simcere’s Phase I Study of The SIM0307 (AER-271), A New Drug for Brain Edema
Simcere Pharmaceutical Group and Aeromics, Inc. today announced that Simcere dosed the first subjects in the…
Syndax Pharmaceuticals Announces Closing of Global Collaboration and License Agreement for Axatilimab
Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX) announced today that the Hart-Scott-Rodino (HSR) antitrust waiting period had expired and…
Immunic, Inc. Announces Enrollment of the First Patient in its Phase 1 Trial of IMU-935 in Metastatic Castration-Resistant Prostate Cancer
Immunic, Inc. (Nasdaq: IMUX),a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating…
PHBI – Phramagreen Targets Making Its Chibafreen Propriety Technology A Cannabis Industry Standard
Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), today released a second management update form CEO Peter Wojcik. Today’s…
DocNow – Reimagining Healthcare on the Digital Sphere
The ‘DocNow’ mobile app features an assortment of provisions that include instant access to user-specific Covid-19…
Aesthetic Lasers and Energy Devices Market to grow by USD 861.45mn|Evolving Opportunities with AbbVie Inc. & Bausch Health Companies Inc.| 17000+ Technavio Reports
The aesthetic lasers and energy devices market report offers information on several market vendors, including AbbVie Inc.,…
New HARMONY Acute Myeloid Leukemia (AML) and Chronic Lymphocytic Leukemia (CLL) Research Results from HARMONY to facilitate tailored treatment choices in subtypes of blood cancer
Big Data analyses have produced novel insights that may improve the prognostication of patients with AML…